Study to Evaluate the Absorption, Distribution, Break Down and Elimination and the Safety of 14C-Labeled Tozadenant
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate how tozadenant is absorbed, distributed, broken
down and eliminated from the body. The compound to be administered will be radiolabeled. This
enables the investigator to trace the compound in blood, urine, feces, expired air and track
what happens to it.